MedTravest II ApS: Financial statements 2022
CVR: 42368032
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
MedTravest II ApS (CVR 42368032) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK -37,952. Equity in the 2022 report amounted to DKK 7,685,969. The solvency ratio was 99.8%.
- Profit/Loss
- DKK -37,952
- Equity
- DKK 7,685,969
- Total Assets
- DKK 7,699,999
- Employees
- 0
Official annual report
Keep an eye on MedTravest II ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
MedTravest II ApS has published its interim report for the period April 23, 2021 to December 31, 2021.
About MedTravest II ApS
MedTravest II ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named ApS STAKE nr. 6158. The management consists of Jens Strathe. The board consists of Mark Lund Andersen (chair), Jens Strathe and Tore Jesper Andersen. The company's owners include STRATHE INVEST ApS, JUUL KRISTENSEN HOLDING ApS and MedTravest A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -186,772 and a net result of DKK -186,772 compared with DKK -23,546 the year before. Equity in the 2025 report amounted to DKK 7,565,001.